Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
IsraelIPO:
29 October 2024Website:
http://www.polyrizon-biotech.comNext earnings report:
N/ALast dividends:
N/ANext dividends:
N/APrice
regular market | Thu, 21 Nov 2024 14:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
Included in screeners
What type of business is Polyrizon?
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a containment barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.
What sector is Polyrizon in?
Polyrizon is in the Healthcare sector
What industry is Polyrizon in?
Polyrizon is in the Biotechnology industry
What country is Polyrizon from?
Polyrizon is headquartered in Israel
When did Polyrizon go public?
Polyrizon initial public offering (IPO) was on 29 October 2024
What is Polyrizon website?
https://www.polyrizon-biotech.com
Is Polyrizon in the S&P 500?
No, Polyrizon is not included in the S&P 500 index
Is Polyrizon in the NASDAQ 100?
No, Polyrizon is not included in the NASDAQ 100 index
Is Polyrizon in the Dow Jones?
No, Polyrizon is not included in the Dow Jones index
When was Polyrizon the previous earnings report?
No data
When does Polyrizon earnings report?
Next earnings report date is not announced yet